chr13-32443085-A-AT
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP5
The NM_001320836.3(N4BP2L2):c.2738_2739insA(p.Asn913LysfsTer2) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000206 in 1,454,142 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (no stars). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000021 ( 0 hom. )
Consequence
N4BP2L2
NM_001320836.3 frameshift
NM_001320836.3 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.123
Genes affected
N4BP2L2 (HGNC:26916): (NEDD4 binding protein 2 like 2) Enables enzyme binding activity. Involved in negative regulation of hematopoietic stem cell differentiation and positive regulation of hematopoietic stem cell proliferation. Located in nucleus. Part of transcription repressor complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 13-32443085-A-AT is Pathogenic according to our data. Variant chr13-32443085-A-AT is described in ClinVar as [Pathogenic]. Clinvar id is 599575.Status of the report is no_assertion_criteria_provided, 0 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
N4BP2L2 | NM_001278432.2 | c.1406_1407insA | p.Asn469LysfsTer2 | frameshift_variant | 7/10 | NP_001265361.1 | ||
N4BP2L2 | NM_001320836.3 | c.2738_2739insA | p.Asn913LysfsTer2 | frameshift_variant | 7/10 | NP_001307765.1 | ||
N4BP2L2 | NM_001387001.1 | c.2738_2739insA | p.Asn913LysfsTer2 | frameshift_variant | 7/10 | NP_001373930.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
N4BP2L2 | ENST00000380121.7 | n.1422_1423insA | non_coding_transcript_exon_variant | 5/8 | 1 | |||||
N4BP2L2 | ENST00000357505.10 | c.1406_1407insA | p.Asn469LysfsTer2 | frameshift_variant | 7/10 | 2 | ENSP00000350104 | |||
N4BP2L2 | ENST00000399396.7 | c.1451_1452insA | p.Asn484LysfsTer2 | frameshift_variant | 7/10 | 5 | ENSP00000382328 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome AF: 0.00000206 AC: 3AN: 1454142Hom.: 0 Cov.: 33 AF XY: 0.00000415 AC XY: 3AN XY: 722944
GnomAD4 exome
AF:
AC:
3
AN:
1454142
Hom.:
Cov.:
33
AF XY:
AC XY:
3
AN XY:
722944
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Short stature Pathogenic:1
Pathogenic, no assertion criteria provided | case-control | Institute of Human Genetics, FAU Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg | Nov 18, 2001 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at